Inquire DOZED Companion Platform Research Protocol Documentation Document analytical protocols, manage project timelines, and access specialized reference tools with DOZED a companion platform for structured research documentation and project management
For maximum benefits, should be administered weekly
They are not intended to represent clinical evidence in humans, and AOD-9604 has not been approved by the FDA, EMA, or any other regulatory authority for any indication
Understanding AOD-9604 mechanism for proper dosing Before calculating your first dose, you need to understand what AOD-9604 actually does at the cellular level
AOD-9604 is the more-studied stabilized version Compound Human Growth Hormone (somatropin) Class Full-length recombinant hGH FDA Status FDA-approved for specific indications (GH deficiency, certain growth disorders, AIDS wasting) Evidence Strength Strong human evidence for approved indications
SC: 5-10mg per injection, 2-3 times per week